SAFE Fertility Group PCL. Shares Clinical Experience with Follitropin Delta in Poor Response Cases at IVF Roundtable Discussion

Bangkok, 6 May 2025 – Dr. Peangpailin Voradithi, a fertility specialist at SAFE Fertility Group PCL., was honored to speak at the IVF Roundtable Discussion, where she presented clinical insights on the use of follitropin delta in patients with poor ovarian reserve, poor response, and unsatisfactory IVF outcomes—a group that often requires more personalized treatment approaches.

Joining the discussion was Mr. Sujin Chanchamroen, Chief Laboratory Officer at SAFE Fertility Group PCL., who provided supporting perspectives from the embryology laboratory, highlighting treatment outcomes achieved through meticulous laboratory protocols and advanced reproductive technologies.

With over 18 years of experience and recognition as the first IVF clinic in Thailand accredited by the RTAC (Australia & New Zealand), SAFE Fertility Group PCL. continues to pioneer patient-centered treatment strategies backed by international standards and innovation.

This participation underscores SAFE Fertility Group PCL.’s ongoing commitment to being a regional leader in reproductive medicine—advancing knowledge, sharing expertise, and delivering excellence to patients in Thailand and across Southeast Asia.